학술논문
109P Impact of anti-drug antibody (ADA) on naxitamab efficacy and safety
Document Type
Abstract
Author
Source
In Immuno-Oncology and Technology December 2022 16 Supplement 1
Subject
Language
ISSN
2590-0188